Insider Trading February 25, 2026

Pitney Bowes Director Sells $1.54 Million in Shares as Company Maneuvers Through Earnings and Debt Plans

Insider sale executed under prearranged 10b5-1 plan; company reports mixed Q4 results and proposes additional senior notes offering

By Hana Yamamoto PBI
Pitney Bowes Director Sells $1.54 Million in Shares as Company Maneuvers Through Earnings and Debt Plans
PBI

Kurt James Wolf, a director at Pitney Bowes Inc., sold 150,000 shares on February 23, 2026, in transactions totaling $1.54 million executed under a Rule 10b5-1 trading plan. The company reported a fourth-quarter beat on adjusted EPS but logged a revenue decline and announced a potential private placement of $200 million in 7.250% Senior Notes due 2029, contingent on market conditions.

Key Points

  • Director Kurt James Wolf sold 150,000 Pitney Bowes shares on Feb. 23, 2026, for a total of $1.54 million at a weighted average price of $10.305.
  • Pitney Bowes reported Q4 adjusted EPS of $0.45, beating estimates by $0.08, while revenue fell to $478 million, below the $486.38 million consensus and down 7% year-over-year.
  • The company proposed a potential private placement of $200 million in 7.250% Senior Notes due 2029, subject to market conditions; the company trades below InvestingPro Fair Value and yields 3.4% in dividends, maintained for 56 consecutive years.

Director Kurt James Wolf of Pitney Bowes Inc. reported the sale of 150,000 shares of common stock on February 23, 2026. The aggregate proceeds from the transactions totaled $1.54 million, reflecting a weighted average price of $10.305 per share.

The individual trades that composed the sale were executed at prices ranging from $10.245 to $10.44. Following these dispositions, Wolf retains a direct holding of 53,789 Pitney Bowes shares.

The sales were carried out pursuant to a prearranged trading arrangement - a Rule 10b5-1 plan - that the director adopted on November 10, 2025. The use of such a plan indicates the trades were scheduled in advance under that program.

On valuation, the company, which has a market capitalization of $1.62 billion, is trading below its InvestingPro Fair Value estimate. That gap is noted as suggesting potential upside for investors relative to the fair value calculation provided by InvestingPro.

Pitney Bowes continues to deliver income to shareholders, offering a 3.4% dividend yield and having maintained dividend payments for 56 consecutive years, according to InvestingPro.

Financial results released for the fourth quarter showed adjusted earnings per share of $0.45, beating analyst expectations by $0.08. Revenue for the quarter came in at $478 million, short of the consensus estimate of $486.38 million and representing a 7% decrease from the $516 million reported in the same period a year earlier.

Alongside the earnings release, the company disclosed plans to offer an additional $200 million in principal amount of its 7.250% Senior Notes due 2029 through a private placement. The new notes are intended to be issued on terms aligned with the existing notes issued in March 2021, with the exception of the initial offering price, issue date, and the date of the first interest payment. The planned offering is explicitly contingent upon market conditions and other factors.

These developments - the director sale executed under a 10b5-1 plan, the mixed quarterly financial print, and the conditional debt placement - together summarize the recent corporate actions and financial items disclosed by Pitney Bowes.

Risks

  • Quarterly revenue declined 7% year-over-year and missed consensus estimates, reflecting near-term top-line pressure that could weigh on equity performance - impacting equity investors and corporate revenue-sensitive sectors.
  • The proposed $200 million senior notes offering is contingent on market conditions and other factors, introducing uncertainty in the companys financing plans and affecting credit markets and fixed-income investors.
  • Insider sales were executed under a prearranged Rule 10b5-1 plan adopted Nov. 10, 2025, which means the transactions followed a pre-scheduled program and may limit interpretation of insider intent, creating uncertainty for governance-focused investors.

More from Insider Trading

325 Capital and Affiliates Sell APEI Shares in $8.7M Disposition Mar 23, 2026 Old Navy CEO Disposes of $2.73M in Gap Inc. Stock; Transaction Carried Out Under 10b5-1 Plan Mar 23, 2026 Alignment Healthcare CEO Disposes $2.06 Million in Stock Mar 23, 2026 Gap CFO Disposes of $278,488 in Stock as Company Reports In-Line Q4 Results Mar 23, 2026 WEX Chief Accounting Officer Disposes of $15,356 in Shares Under 10b5-1 Plan Mar 23, 2026